| Literature DB >> 29710823 |
Ting He1, Jiang Zhu2, Yao Nie3, Rui Hu4, Ting Wang5, Peiwu Li6, Qi Zhang7, Yunhuang Yang8.
Abstract
Mycotoxins, which are toxic, carcinogenic, and/or teratogenic, have posed a threat to food safety and public health. Sensitive and effective determination technologies for mycotoxin surveillance are required. Immunoassays have been regarded as useful supplements to chromatographic techniques. However, conventional antibodies involved in immunoassays are difficult to be expressed recombinantly and are susceptible to harsh environments. Nanobodies (or VHH antibodies) are antigen-binding sites of the heavy-chain antibodies produced from Camelidae. They are found to be expressed easily in prokaryotic or eukaryotic expression systems, more robust in extreme conditions, and facile to be used as surrogates for artificial antigens. These properties make them the promising and environmentally friendly immunoreagents in the next generation of immunoassays. This review briefly describes the latest developments in the area of nanobodies used in mycotoxin detection. Moreover, by integrating the introduction of the principle of nanobodies production and the critical assessment of their performance, this paper also proposes the prospect of nanobodies in the field of food safety in the foreseeable future.Entities:
Keywords: Food safety; Immunoassay; Mycotoxins; Nanobody
Mesh:
Substances:
Year: 2018 PMID: 29710823 PMCID: PMC5983236 DOI: 10.3390/toxins10050180
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
The major fungal producers, hosts, toxic effects of mycotoxins, and their maximum permitted levels in food according to European legislation.
| Mycotoxins | Major Producers | Major Host | Toxin Effects | Maximum Level |
|---|---|---|---|---|
| Aflatoxins | maize, nuts, | hepatotoxicity, cancer, immunosuppression | 8.0 μg/kg (AFB1); | |
| Fumonisins | maize | hepatotoxicity, | 4000 μg/kg in maize; | |
| Deoxynivalenol | maize, wheat, barley | gastrointestinal toxicity, inflammation of central nervous system | 1250 μg/kg in cereals | |
| Zearalenone | maize, barley, wheat, rice | infertility, | 350 μg/kg in maize; | |
| OchratoxinA | cereal-derived products, | nephrotoxic, carcinogenic, teratogenic, immunotoxic effects | 5.0 μg/kg in maize | |
| Citrinin | corn, wheat, barley, rice | nephrotoxic, hepatotoxic, immunotoxic, carcinogenic effects | 2000 μg/kg |
Figure 1Schematic representation of a (A) conventional antibody (IgG) and (B) heavy chain camelid antibody. The isolated variable domain of the latter is called nanobody.
Figure 2Schematic representation of the construction of phage-displayed nanobody library and the strategy of panning for the high-affinity Nbs isolation.
Nbs to mycotoxins to date and comparison of sensitivities to monoclonal antibodies and polyclonal antibodies.
| Mycotoxin | Antibody | Assay Format | Sensitivity, IC50 |
|---|---|---|---|
| AFB1 | Nb | icELISA [ | 0.754 ng/mL |
| mAb | icELISA [ | 0.0002 ng/mL | |
| pAb | icELISA [ | 2.0 ng/mL | |
| OTA | Nb | icELISA [ | 0.64 ng/mL |
| mAb | icELISA [ | 0.058 ng/mL | |
| pAb | icELISA [ | 5.0 ng/mL | |
| 15-acetyl-DON | Nb | fluorescence polarization [ | 419 ng/mL |
| mAb | dcELISA [ | 1000 ng/mL | |
| pAb | dcELISA [ | 1.9 ng/mL |
Some applications and the performance of Nbs used for mycotoxin detection.
| Targets (MW). | NB TYPE | Assay Formats, (Ref.) | Sensitivity, IC50; Linear Range, IC20–IC80; LOD, IC10 | Specificity (CR) | Thermal Stability | Solvent/Matrix Stability |
|---|---|---|---|---|---|---|
| OTA (403.813) | Anti-hapten Nb | icELISA [ | IC50: 0.64 ng/mL; | not tested | 95 °C for 5min, retained45% of binding activity; | dilution factor ×2.5 eliminate the matrix interference |
| Nb-AP | dcELISA [ | IC50: 0.13 ng/mL; | CR: 0.1% with OTB, ZEN, DON, and AFB1 | not tested | Susceptive to methanol, ionic strength and low pH (≤6.0) | |
| phage-Nb | Nb-IPCR [ | LR: 10−5–1.0 ng/mL; | CR: 3.5% with OTB; | not tested | not tested | |
| phage-AI-Nb | AI-Nb-IPCR [ | LR: 0.01–10 ng/mL; | CR: 0.1% with FB1, ZEN, DON, and AFB1 | not tested | susceptive to methanol over 10% | |
| AFB1 (312.27) | Anti-hapten Nb | icELISA [ | IC50: 0.754 ng/mL; | CR: 10% with AFB2, AFG1, and AFG2 | 85 °C for 60 min, retained40% of binding activity | stable in 40% methanol and 40% acetone |
| phage-AI-Nb | AI-Nb-IPCR [ | LOD: 0.02 ng/mL | CR: 50% with AFB2 and AFG1; 13.5% with AFG2 | not tested | susceptive to methanol over 10% | |
| AI-Nb | AI-ELISA [ | IC50: 0.16 ng/mL; | CR: 50% with AFB2 and AFG1; | 80 °C for 60 min, retained | stable in methanol below 40% | |
| AI-Nb | TRFICA [ | IC50: 0.46 ng/mL; | CR: 50% with AFB2 and AFG1; 31.1% with AFG2; 19.4% with AFM1 | not tested | not tested | |
| ZEN (318.37) | phage-AI-Nb | AI-Nb-IPCR [ | LR: 0.01–10 ng/mL; | CR: 0.1% with AFB1, DON, and OTA | not tested | susceptive to methanol over 5% |
| AI-Nb | TRFICA [ | IC50: 0.86 ng/mL; | CR: 78.1% with β-zearalenol | not tested | not tested | |
| 15-acetyl-DON (338.35) | Anti-hapten Nb | fluorescence polarization [ | IC50: 419.5 ng/mL (monomer) | CR: 0.1% with neosolaniol, diacetoxyscirpenol, and T-2 toxin | not tested | not tested |
| DON (296.32) | AI-Nb | AI-ELISA [ | IC50: 8.77 ng/mL; | CR: 0.1% with FB1, ZEN, AFB1, and OTA | 95 °C for 5 min, retained60% of binding activity | not tested |
| phage-AI-Nb | AI-PELISA [ | IC50: 24.49 ng/mL; | CR: 0.1%with FB1, ZEN, AFB1, and OTA | 95 °C for 5 min, retained55% of binding activity | stable in ionic strength below 50 mM and pH between 5.0 and 8.0 | |
| FB1 (721.84) | AI-Nb | AI-ELISA [ | IC50: 0.95 ng/mL; | CR: 4.93% with FB2 | not tested | stable in ionic strength below 50 mM and pH between 5.0 and 8.0 |
| CIT (250.25) | AI-Nb | AI-ELISA [ | IC50: 44.6 ng/mL; | CR: 0.1% with AFB1, ZEN, DON, and OTA | not tested | susceptive to methanol over 20% |
| phage-AI-Nb | AI-PELISA [ | IC50: 10.9 ng/mL; | CR: 0.1% with AFB1, ZEN, DON, and OTA | not tested | stable in methanol below 25%, ionic strength below 55 mM and pH between 5.4 and 9.0 |
Abbreviations used: (1) MW, molecular weight; (2) IC50, IC20–IC80, IC10, concentrations resulting in 50, 20-80 or 10% decrease in maximum signal; (3) LR, linear range; (4) LOD, limit of detection; (5) CR, cross-reactivity; (6) ELISA, enzyme linked immunosorbent assay; (7) ic-ELISA, indirect competitive ELISA; (8) dc-ELISA, direct competitive ELISA; (9) Nb-IPCR, Nb-based phage displayed immune PCR; (10) AI-Nb-IPCR, anti-idiotypic Nb based phage displayed immune PCR; (11) AI-ELISA, anti-idiotypic Nb based ELISA; (12) AI-PELISA, anti-idiotypic Nb-based phage ELISA; (13) TRFICA, time-resolved fluorescence immunochromatographic assay; (14) Nb-AP, Nb-alkaline phosphatase fusion protein; (15) phage-Nb, phage-displayed Nb; (16) phage-AI-Nb, phage-displayed anti-idiotypic Nb. * units converted to ng/mL from initial publication.
Figure 3Schematic diagram of Nb-based competitive ELISA formats. The direct assays do not use second antibody and have one less step than the indirect assays. (A) Nb-based icELISA; (B) anti-idiotypic Nb-based icELISA, AI-ELISA; (C) Nb-based dcELISA; (D) anti-idiotypic Nb-based dcELISA, AI-dcELISA.
Figure 4Schematic diagram of the real-time phage display mediated immune-PCR assay. (Reprinted with permission from reference [83], Copyright (2014), American Chemical Society.)
Figure 5Schematic illustration of AI-Nb-based time-resolved fluorescence immunochromatographic assay for dual mycotoxins. (Reprinted with permission from reference [84], Copyright (2017), American Chemical Society.)